中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
The Chinese Journal of Clinical Pharmacology
2015年
20期
2027-2030
,共4页
王维%李海林%韩光宁%宋国权%代海平%彭永海
王維%李海林%韓光寧%宋國權%代海平%彭永海
왕유%리해림%한광저%송국권%대해평%팽영해
柴胡皂苷d%肝癌%增殖细胞核抗原%MKI-67基因编码核蛋白
柴鬍皂苷d%肝癌%增殖細胞覈抗原%MKI-67基因編碼覈蛋白
시호조감d%간암%증식세포핵항원%MKI-67기인편마핵단백
saikosaponin d%hepatocellular carcinoma%proliferating cell nuclear antigen%MKI -67 gene encodes nuclear protein
目的:评价柴胡皂苷d在二乙基亚硝胺诱发的肝癌模型大鼠体内的药效学。方法将60只建模成功的SD大鼠随机分为模型组、实验组及对照组,每组20只;20只未处理的 SD 大鼠为安慰剂组。实验组予以腹腔注射10 mg? kg-1柴胡皂苷d注射液,每日1次;对照组予以腹腔注射200 mg? kg-1沙利度胺注射液,每日1次;模型组和安慰剂组均腹腔注射0.9%氯化钠注射液2 mL,每日1次。所有干预均连续6周。干预结束后,用生化分析法检测大鼠肝功能指标,用免疫组化法检测增殖细胞核抗原( PCNA)和MKI-67基因编码核蛋白( Ki-67)表达,用HE染色法观察肝组织病理学形态。结果与模型组相比,实验组与对照组的肝功能指标较低( P<0.05), PCNA和Ki-67表达较低( P<0.05)。与对照组相比,实验组中各项肝功指标较低( P<0.05), PCNA和Ki-67表达较低(P<0.05)。安慰剂组的肝病理切片显示正常的肝小叶结构完整,肝索周围规整,肝细胞索排列整齐,细胞核清晰。模型组显示癌灶呈现片状坏死,正常肝小叶结构被破坏,白色结节处为肝癌细胞。对照组仍能观察到少量恶性度较低以及局灶性坏死的癌细胞,并且有较少的核分裂象,实验组的肝组织肝血窦中有少量充血,极少的核分裂象。结论柴胡皂苷d能显著改善肝癌模型大鼠的肝功能,修复损伤的肝细胞,降低肝癌模型大鼠PCNA和Ki-67蛋白的表达量。
目的:評價柴鬍皂苷d在二乙基亞硝胺誘髮的肝癌模型大鼠體內的藥效學。方法將60隻建模成功的SD大鼠隨機分為模型組、實驗組及對照組,每組20隻;20隻未處理的 SD 大鼠為安慰劑組。實驗組予以腹腔註射10 mg? kg-1柴鬍皂苷d註射液,每日1次;對照組予以腹腔註射200 mg? kg-1沙利度胺註射液,每日1次;模型組和安慰劑組均腹腔註射0.9%氯化鈉註射液2 mL,每日1次。所有榦預均連續6週。榦預結束後,用生化分析法檢測大鼠肝功能指標,用免疫組化法檢測增殖細胞覈抗原( PCNA)和MKI-67基因編碼覈蛋白( Ki-67)錶達,用HE染色法觀察肝組織病理學形態。結果與模型組相比,實驗組與對照組的肝功能指標較低( P<0.05), PCNA和Ki-67錶達較低( P<0.05)。與對照組相比,實驗組中各項肝功指標較低( P<0.05), PCNA和Ki-67錶達較低(P<0.05)。安慰劑組的肝病理切片顯示正常的肝小葉結構完整,肝索週圍規整,肝細胞索排列整齊,細胞覈清晰。模型組顯示癌竈呈現片狀壞死,正常肝小葉結構被破壞,白色結節處為肝癌細胞。對照組仍能觀察到少量噁性度較低以及跼竈性壞死的癌細胞,併且有較少的覈分裂象,實驗組的肝組織肝血竇中有少量充血,極少的覈分裂象。結論柴鬍皂苷d能顯著改善肝癌模型大鼠的肝功能,脩複損傷的肝細胞,降低肝癌模型大鼠PCNA和Ki-67蛋白的錶達量。
목적:평개시호조감d재이을기아초알유발적간암모형대서체내적약효학。방법장60지건모성공적SD대서수궤분위모형조、실험조급대조조,매조20지;20지미처리적 SD 대서위안위제조。실험조여이복강주사10 mg? kg-1시호조감d주사액,매일1차;대조조여이복강주사200 mg? kg-1사리도알주사액,매일1차;모형조화안위제조균복강주사0.9%록화납주사액2 mL,매일1차。소유간예균련속6주。간예결속후,용생화분석법검측대서간공능지표,용면역조화법검측증식세포핵항원( PCNA)화MKI-67기인편마핵단백( Ki-67)표체,용HE염색법관찰간조직병이학형태。결과여모형조상비,실험조여대조조적간공능지표교저( P<0.05), PCNA화Ki-67표체교저( P<0.05)。여대조조상비,실험조중각항간공지표교저( P<0.05), PCNA화Ki-67표체교저(P<0.05)。안위제조적간병리절편현시정상적간소협결구완정,간색주위규정,간세포색배렬정제,세포핵청석。모형조현시암조정현편상배사,정상간소협결구피파배,백색결절처위간암세포。대조조잉능관찰도소량악성도교저이급국조성배사적암세포,병차유교소적핵분렬상,실험조적간조직간혈두중유소량충혈,겁소적핵분렬상。결론시호조감d능현저개선간암모형대서적간공능,수복손상적간세포,강저간암모형대서PCNA화Ki-67단백적표체량。
Objective To evaluate the pharmacodynamics of saikosapo-nin d ( SSd) in the treatment of hepatoma model rat.Methods Sixty SD rats with succeed modeling were randomly divided into model group ( n=20 ) , experimental group ( n=20 ) and control group ( n=20 ) , 20 SD rats without modeling were conducted to placebo group.The experi-mental group was treated with SSd 10 mg? kg -1 once a day, the control group was treated with thalidomide 200 mg? kg -1 once a day, the place-bo group and model group were treated with 0.9% NaCI 2 mL once a day.Liver function index were compared by Biochemical analysis me-thod, proliferating cell nuclear antigen ( PCNA) and MKI-67 gene en-codes nuclear protein(Ki-67) were compared by immunohistochemistry after 6 weeks.Results Compared with the model group, liver function index as well as the expression of PCNA and Ki-67 of the control group and the experiment group were lower (P<0.05).Compared with the control group, liver function index with expression of PCNA and Ki-67 of the experiment group were lower ( P<0.05).Pathological display:the pathological sections of the liver in the placebo group showed that the structure of the normal liver was complete, the liver cells were neat, the liver cells were arranged regularly, and the nu-cleus was clear.The model group showed that the tumor foci were in the shape of the necrosis, and the structure of the normal liver was destroyed, and the white nodules were the liver cancer cells.A small amount of low malignant degree, focal necrosis of cancer cells and fewer mitoses could be observed in control group, a small amount of blood and rare mitotic figures could be seen in the experiment group.Conclusion SSd can significantly improve liver function, repair the damage of liver cells, and reduce protein expression of PCNA and Ki-67 in model rats.